Europe animal healthcare market encompasses various pharmaceuticals and vaccines products catering to the pet healthcare needs. Factors such as rising pet adoption, increasing awareness about pet care, growing pet humanization trend, and rising pet healthcare spending are expected to drive the demand for various veterinary medicines and vaccines in Europe. The market offers diverse range of medicinal products like anesthetics, dental care, dermatology, anti-infectives, reproductive, nutritional, and others. Growing adoption of pets along with increasing disposable income of people for pet grooming is anticipated to boost the Europe animal healthcare industry during the projected timeline.
Key Takeaways
Key players operating in the Europe animal healthcare are Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company. These players are involved in various strategic initiatives like mergers, acquisitions, and product launches to strengthen their market position.
The demand for various animal healthcare products especially medicines and vaccines is growing at a robust rate due to rising pet adoption and increasing animal healthcare spending in Europe. Growing humanization of pets and rising awareness about animal welfare is further driving the sales of animal medicines and healthcare solutions across the region.
The Europe animal healthcare market is also witnessing high growth opportunities due to global expansion strategies adopted by leading market players via partnerships and by expanding their manufacturing and distribution footprint across high potential countries. Increased R&D investments by companies for development of novel and advanced animal drugs and vaccines is also supporting the Europe animal healthcare market growth.
Market Drivers
Increasing pet population along with rising disposable income especially in countries like the UK, Germany, France, and Italy is a key factor fueling the growth of Europe animal healthcare market. Spending on pet grooming and wellness has increased substantially over the past few years due to growing humanization of pets. Moreover, rising awareness about pet care via social media influence and education is driving the adoption of various veterinary solutions like medicines and vaccines in the region.
The current geopolitical uncertainty and instability in several European countries is impacting the growth of the animal healthcare market in Europe. The Russia-Ukraine conflict and economic sanctions on Russia by European nations and their allies has significantly disrupted supply chains and logistics network. This has led to shortages and price increases of several raw materials used in animal medicine manufacturing like vitamins and minerals. The conflict is also generating refugee crisis which is placing additional burden on healthcare infrastructure and resources. All these factors are negatively impacting the overall expenditure on animal healthcare in affected countries and region.
To overcome these challenges, market players need to diversify their supplier networks and establish alternative sources for raw materials. They should look for strategic tie-ups or acquisitions that can help gain access to new material sources and manufacturing capabilities outside the conflict zones. Adopting flexible pricing models and prioritizing continuity of supplies for critical medicines can help sustain demand from veterinarians and livestock farmers during economic volatility. Enhancing digital capabilities for virtual care, remote monitoring and teleconsultation can also help serve customers in difficult geo-political conditions with minimum disruptions.
In terms of value, Western Europe accounted for the largest share of over 45% in the Europe animal healthcare market in 2024 led by countries like Germany, France, UK and Italy. This region has robust livestock industry and pet ownership. However, Central and Eastern Europe is expected to be the fastest growing region during the forecast period due to increasing per capita income, growing meat consumption and expanding veterinary infrastructure in countries like Poland, Romania and Hungary.
The Western Europe region has the highest concentration of cattle, poultry and pig population and is a major dairy and meat producer globally. It also has over 100 million pet dogs and cats which is driving significant demand for vaccines, antibiotics, parasiticides and other veterinary supplies. However, Central and Eastern Europeregion is growing at a fast pace as livestock farming is becoming more commercial and standards of animal welfare are improving in these nations. Countries like Poland, Romania and Hungary are witnessing expansion of veterinary education and facilities. Rising affordability is also contributing to increased spending on animal health in this high potential region of Europe.
Geographical regions where market in terms of value is concentrated and another about the fastest growing region for given market. Do not write conclusion anywhere in the output I repeat do not write conclusion. Given market name and other data: Market Name- Europe Animal Healthcare Market; CAGR: 4.8%; Forecast period is: 2023 to 2030; Market Size for 2024 is US$ 14,096.3 Mn; Key players: Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company
Comments
0 comment